Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness

Nature Communications

Volumn 7, Issue , 2016, Pages

  Avgustinova, Alexandra ^a,d   Iravani, Marjan ^a   Robertson, David ^a   Fearns, Antony ^a   Gao, Qiong ^a   Klingbeil, Pamela ^a,e   Hanby, Andrew M ^b   Speirs, Valerie ^b   Sahai, Erik ^c   Calvo, Fernando ^a,c   Isacke, Clare M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c THE FRANCIS CRICK INSTITUTE   (United Kingdom)

^d INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^e EVOTEC AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR; WNT7A PROTEIN; WNT PROTEIN; WNT7A PROTEIN, MOUSE;

CANCER; CELLS AND CELL COMPONENTS; COHORT ANALYSIS; DISEASE; GENE EXPRESSION; PHENOTYPE; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER PROGNOSIS; CELL ACTIVATION; CONTROLLED STUDY; DISTANT METASTASIS; ENVIRONMENT; FIBROBLAST; IN VITRO STUDY; METASTASIS; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PROTEIN EXPRESSION; STROMA; TUMOR CELL; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NIH 3T3 CELL LINE;

ANIMALS; BREAST NEOPLASMS; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED BALB C; NIH 3T3 CELLS; WNT PROTEINS;

EID: 84954525154     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10305     Document Type: Article

References (58)

1. De Wever, O., Demetter, P., Mareel, M. & Bracke, M. Stromal myofibroblasts are drivers of invasive cancer growth. Int. J. Cancer 123, 2229-2238 (2008).
2. Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nat. Rev. Cancer 6, 392-401 (2006).
3. Pietras, K. & Ostman, A. Hallmarks of cancer: interactions with the tumour stroma. Exp. Cell Res. 316, 1324-1331 (2010).
4. Schafer, M. & Werner, S. Cancer as an overhealing wound: an old hypothesis revisited. Nat. Rev. Mol. Cell Biol. 9, 628-638 (2008).
5. Cirri, P. & Chiarugi, P. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer Metastasis Rev. 31, 195-208 (2012).
6. Cardone, A., Tolino, A., Zarcone, R., Borruto Caracciolo, G. & Tartaglia, E. Prognostic value of desmoplastic reaction and lymphocytic infiltration in the management of breast cancer. Panminerva Med. 39, 174-177 (1997).
7. Paraiso, K. H. & Smalley, K. S. Fibroblast-mediated drug resistance in cancer. Biochem. Pharmacol. 85, 1033-1041 (2013).
8. Ohlund, D., Elyada, E. & Tuveson, D. Fibroblast heterogeneity in the cancer wound. J. Exp. Med. 211, 1503-1523 (2014).
9. Sugimoto, H., Mundel, T. M., Kieran, M. W. & Kalluri, R. Identification of fibroblast heterogeneity in the tumour microenvironment. Cancer Biol. Ther. 5, 1640-1646 (2006).
10. Paulsson, J. et al. Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer. Am. J. Pathol. 175, 334-341 (2009).
11. Simpkins, S. A., Hanby, A. M., Holliday, D. L. & Speirs, V. Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts. J. Pathol. 227, 490-498 (2012).
12. Busch, S., Ryden, L., Stal, O., Jirstrom, K. & Landberg, G. Low ERK phosphorylation in cancer-associated fibroblasts is associated with tamoxifen resistance in pre-menopausal breast cancer. PLoS ONE 7, e45669 (2012).
13. Aslakson, C. J., McEachern, D., Conaway, D. H. & Miller, F. R. Inhibition of lung colonization at two different steps in the metastatic sequence. Clin. Exp. Metastasis 9, 139-150 (1991).
14. Aslakson, C. J. & Miller, F. R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumour. Cancer Res. 52, 1399-1405 (1992).
15. Miller, F. R., Miller, B. E. & Heppner, G. H. Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumour: heterogeneity in phenotypic stability. Invasion Metastasis 3, 22-31 (1983).
16. MacFadyen, J. R. et al. Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium. FEBS Lett. 579, 2569-2575 (2005).
17. Simonavicius, N. et al. Endosialin (CD248) is a marker of tumour-associated pericytes in high-grade glioma. Mod. Pathol. 21, 308-315 (2008).
18. Untergasser, G. et al. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation. Mech. Ageing Dev. 126, 59-69 (2005).
19. Hawinkels, L. J. et al. Interaction with colon cancer cells hyperactivates TGF-beta signaling in cancer-associated fibroblasts. Oncogene 33, 97-107 (2012).
20. Kojima, Y. et al. Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumour-promoting mammary stromal myofibroblasts. Proc. Natl Acad. Sci. USA 107, 20009-20014 (2010).
21. Van Obberghen-Schilling, E., Roche, N. S., Flanders, K. C., Sporn, M. B. & Roberts, A. B. Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. J. Biol. Chem. 263, 7741-7746 (1988).
22. Calvo, F. et al. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat. Cell Biol. 15, 637-646 (2013).
23. Cygan, J. A., Johnson, R. L. & McMahon, A. P. Novel regulatory interactions revealed by studies of murine limb pattern in Wnt-7a and En-1 mutants. Development 124, 5021-5032 (1997).
24. Hall, A. C., Lucas, F. R. & Salinas, P. C. Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling. Cell 100, 525-535 (2000).
25. Parr, B. A. & McMahon, A. P. Dorsalizing signal Wnt-7a required for normal polarity of D-V and A-P axes of mouse limb. Nature 374, 350-353 (1995).
26. Miyoshi, H., Ajima, R., Luo, C. T., Yamaguchi, T. P. & Stappenbeck, T. S. Wnt5a potentiates TGF-beta signaling to promote colonic crypt regeneration after tissue injury. Science 338, 108-113 (2012).
27. Bentzinger, C. F. et al. Fibronectin regulates wnt7a signaling and satellite cell expansion. Cell Stem Cell 12, 75-87 (2013).
28. Moreno-Estelles, M. et al. Symmetric expansion of neural stem cells from the adult olfactory bulb is driven by astrocytes via WNT7A. Stem Cells 30, 2796-2809 (2012).
29. Carmon, K. S. & Loose, D. S. Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells. Mol. Cancer Res. 6, 1017-1028 (2008).
30. Yoshioka, S. et al. WNT7A regulates tumour growth and progression in ovarian cancer through the WNT/beta-catenin pathway. Mol. Cancer Res. 10, 469-482 (2012).
31. Lyu, J. & Joo, C. K. Wnt-7a up-regulates matrix metalloproteinase-12 expression and promotes cell proliferation in corneal epithelial cells during wound healing. J. Biol. Chem. 280, 21653-21660 (2005).
32. Le Grand, F., Jones, A. E., Seale, V., Scime, A. & Rudnicki, M. A. Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells. Cell Stem Cell 4, 535-547 (2009).
33. Ciani, L. et al. Wnt7a signaling promotes dendritic spine growth and synaptic strength through Ca(2)(+)/Calmodulin-dependent protein kinase II. Proc. Natl Acad. Sci. USA 108, 10732-10737 (2011).
34. Bierie, B. & Moses, H. L. TGF-beta and cancer. Cytokine Growth Factor Rev. 17, 29-40 (2006).
35. Desmouliere, A., Geinoz, A., Gabbiani, F. & Gabbiani, G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 122, 103-111 (1993).
36. Lewis, M. P. et al. Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br. J. Cancer 90, 822-832 (2004).
37. Chang, H. Y. et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc. Natl Acad. Sci. USA 102, 3738-3743 (2005).
38. Calon, A. et al. Dependency of colorectal cancer on a TGF-beta-driven program in stromal cells for metastasis initiation. Cancer Cell 22, 571-584 (2012).
39. Finak, G. et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat. Med. 14, 518-527 (2008).
40. Eckhardt, B. L. et al. Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. Mol. Cancer Res. 3, 1-13 (2005).
41. Lou, Y. et al. Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis. Dev. Dyn. 237, 2755-2768 (2008).
42. Yang, J. et al. Twist, a master regulator of morphogenesis, plays an essential role in tumour metastasis. Cell 117, 927-939 (2004).
43. Attisano, L. & Wrana, J. L. Signal integration in TGF-beta, WNT, and Hippo pathways. F1000prime Rep. 5, 17 (2013).
44. Attisano, L. & Labbe, E. TGFbeta and Wnt pathway cross-talk. Cancer Metastasis Rev. 23, 53-61 (2004).
45. Kumawat, K. et al. Noncanonical WNT-5A signaling regulates TGF-beta-induced extracellular matrix production by airway smooth muscle cells. FASEB J. 27, 1631-1643 (2013).
46. Akhmetshina, A. et al. Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nat. Commun. 3, 735 (2012).
47. Miyoshi, H. & Stappenbeck, T. S. Counteracting stem cell expansion during wound repair: distinct roles of non-canonical Wnt and TGF-beta. Cell Cycle 12, 387-388 (2013).
48. Gough, N. R. Focus issue: an expanding world for TGF-beta signaling. Sci. Signal. 1, eg8 (2008).
49. Ren, S. et al. LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1. Proc. Natl Acad. Sci. USA 110, 1440-1445 (2013).
50. Ishiguro, K. et al. Syndecan-4 deficiency leads to high mortality of lipopolysaccharide-injected mice. J. Biol. Chem. 276, 47483-47488 (2001).
51. MacFadyen, J., Savage, K., Wienke, D. & Isacke, C. M. Endosialin is expressed on stromal fibroblasts and CNS pericytes in mouse embryos and is downregulated during development. Gene Expr. Patterns 7, 363-369 (2007).
52. Schaefer, B. C., Schaefer, M. L., Kappler, J. W., Marrack, P. & Kedl, R. M. Observation of antigen-dependent CD8+ T-cell/ dendritic cell interactions in vivo. Cell Immunol. 214, 110-122 (2001).
53. Curino, A. C. et al. Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy. J. Cell Biol. 169, 977-985 (2005).
54. Isacke, C. M., van der Geer, P., Hunter, T. & Trowbridge, I. S. p180, a novel recycling transmembrane glycoprotein with restricted cell type expression. Mol. Cell Biol. 10, 2606-2618 (1990).
55. Robertson, D., Savage, K., Reis-Filho, J. & Isacke, C. Multiple immunofluorescence labelling of formalin-fixed paraffin-embedded (FFPE) tissue. BMC Cell Biol. 9, 13 (2008).
56. Reis-Filho, J. S. et al. Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue. Mod. Pathol. 19, 307-319 (2006).
57. Gyorffy, B., Lanczky, A. & Szallasi, Z. Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. Endocr. Relat. cancer 19, 197-208 (2012).
58. Loi, S. et al. PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer. Proc. Natl Acad. Sci. USA 107, 10208-10213 (2010).